| Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers. | |
| | |
MedLine Citation:
|
PMID: 22401133 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Objectives: To study (i) the drug utilization pattern of anti-rheumatic drugs in pregnant women and expectant fathers and (ii) the association between the use of anti-rheumatic drugs during pregnancy and the risk of congenital malformations. Method: Pregnancies registered in the Medical Birth Registry of Norway (MBRN) were linked to the Norwegian Prescription Database (NorPD) in the period 2004-2007. Prescriptions for anti-rheumatic drugs issued to women 3 months prior to and during pregnancy and to men 3 months prior to conception were identified. Congenital malformations were recorded according to the European Surveillance of Congenital Anomalies (EUROCAT) guidelines. Results: In 154 976 singleton pregnancies, 1461 of the women (0.9%) and 1198 (0.8%) of the known fathers (150 530) were dispensed anti-rheumatic drugs at least once during the study period: 723 had non-steroidal anti-inflammatory drugs (NSAIDs), 633 prednisolone (CS), 119 sulfasalazine (SASP), 101 azathioprine (AZA), 58 hydroxychloroquine (HQC), 37 etanercept (ETAN), eight methotrexate (MTX), two leflunomide (LEF), and three adalumimab (ADA). Odds ratios (ORs) for malformations in children born of women (w) or men (m) who had received the drugs were OR(w) = 1.06 [95% confidence interval (CI) 0.85-1.32] and OR(m) = 1.19 (95% CI 0.93-1.51), respectively, and for major malformation OR(w) = 1.05 (95% CI 0.79-1.40) and OR(m) = 1.26 (95% CI 0.93-1.71), respectively. None of the children whose mother had received MTX, LEF, ETAN, or ADA were reported to be born with major malformations. Conclusions: This study revealed no major malformations of the alert drugs MTX, LEF, ETAN, or ADA. Although the numbers are limited, this provides important population-based information to both expectant parents and prescribers. |
| | |
Authors:
|
Kk Viktil; A Engeland; K Furu |
Related Documents
:
|
22888273 - Characterization of hiv-1 antiretroviral drug resistance after second-line treatment fa... 22583363 - Primary drug resistance to anti-tuberculosis drugs in major towns of amhara region, eth... 6539933 - Comparison of the stimulatory effects of eight antiparkinsonian drugs. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-9 |
Journal Detail:
|
Title: Scandinavian journal of rheumatology Volume: - ISSN: 1502-7732 ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-3-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0321213 Medline TA: Scand J Rheumatol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Diakonhjemmet Hospital Pharmacy , Oslo , Norway. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sequence, Structure, and Function of Peptide Self-assembled Monolayers.
Next Document: Mechanism of binding of NO to soluble guanylyl cyclase: implication for the second NO binding to the...